Tarsus Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 3.60 M | $252.54 M | 19.84% | 8.41% |
| BLACKROCK, INC. | 05/13/2026 | 3.55 M | $249.22 M | -6.28% | 8.30% |
| RTW INVESTMENTS, LP | 05/15/2026 | 3.35 M | $234.72 M | 0.32% | 7.82% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 2.56 M | $179.74 M | 0.00% | 5.99% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 2.24 M | $157.22 M | 16.09% | 5.24% |
| MORGAN STANLEY | 05/15/2026 | 1.94 M | $136.39 M | -4.73% | 4.54% |
| 05/15/2026 | 1.76 M | $123.50 M | 100.00% | 4.11% | |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 1.71 M | $120.11 M | -23.23% | 4.00% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/20/2026 | 1.28 M | $89.81 M | 13.52% | 2.99% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.19 M | $83.79 M | 57.55% | 2.79% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.19 M | $83.38 M | 0.00% | 2.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.12 M | $78.66 M | 18.29% | 2.62% |
| STATE STREET CORP | 05/15/2026 | 978.21 K | $68.62 M | 5.29% | 2.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2026 | 926.13 K | $64.97 M | -21.01% | 2.16% |
| LORD, ABBETT & CO. LLC | 05/14/2026 | 842.31 K | $59.09 M | -1.56% | 1.97% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 791.15 K | $55.50 M | 28.61% | 1.85% |
| INVESCO LTD. | 05/12/2026 | 742.50 K | $52.09 M | -26.66% | 1.74% |
| FMR LLC | 05/15/2026 | 733.33 K | $51.44 M | 13.32% | 1.71% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 728.64 K | $51.11 M | 0.00% | 1.70% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 564.58 K | $39.61 M | 382.53% | 1.32% |
| CLEARBRIDGE INVESTMENTS, LLC | 05/13/2026 | 545.35 K | $38.26 M | 7.76% | 1.27% |
| TORONTO DOMINION BANK | 05/15/2026 | 510.25 K | $35.79 M | 0.00% | 1.19% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 05/15/2026 | 499.85 K | $35.07 M | -14.51% | 1.17% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 439.63 K | $30.84 M | 16.09% | 1.03% |
| LOOMIS SAYLES & CO L P | 05/14/2026 | 407.84 K | $28.61 M | -7.70% | 0.95% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 05/07/2026 | 388.59 K | $27.26 M | 16.89% | 0.91% |
| NORTHERN TRUST CORP | 05/14/2026 | 352.96 K | $24.76 M | 3.06% | 0.83% |
| 05/08/2026 | 335.89 K | $23.56 M | 100.00% | 0.79% | |
| FRANKLIN RESOURCES INC | 05/13/2026 | 333.68 K | $23.41 M | -0.99% | 0.78% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 332.98 K | $23.36 M | -29.76% | 0.78% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 329.75 K | $23.13 M | 0.27% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 328.16 K | $23.02 M | -1.49% | 0.77% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 324.01 K | $22.73 M | -19.25% | 0.76% |
| NUVEEN, LLC | 04/30/2026 | 315.29 K | $22.12 M | -2.24% | 0.74% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/13/2026 | 307.31 K | $21.56 M | -29.61% | 0.72% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 303.51 K | $21.29 M | -14.77% | 0.71% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 274.80 K | $19.28 M | -47.03% | 0.64% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 272.74 K | $19.13 M | 100.00% | 0.64% |
| BRAIDWELL LP | 05/15/2026 | 265.72 K | $18.64 M | 100.00% | 0.62% |
| TRI LOCUM PARTNERS LP | 05/18/2026 | 252.59 K | $17.72 M | 100.00% | 0.59% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 241.03 K | $16.91 M | 1,003.98% | 0.56% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 226.25 K | $15.87 M | 501.28% | 0.53% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 225.18 K | $15.80 M | -13.51% | 0.53% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 225.00 K | $15.78 M | -10.00% | 0.53% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 200.00 K | $14.03 M | 100.00% | 0.47% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 200.00 K | $14.03 M | 0.00% | 0.47% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 200.00 K | $14.03 M | 100.00% | 0.47% |
| JANE STREET GROUP, LLC | 05/12/2026 | 192.00 K | $13.47 M | 4.18% | 0.45% |
| M&G PLC | 05/13/2026 | 166.36 K | $11.65 M | 100.00% | 0.39% |
| CITADEL ADVISORS LLC | 05/15/2026 | 164.00 K | $11.50 M | 100.00% | 0.38% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tarsus Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 303 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals Inc. The most heavily invested institutionals were:
Deep Track Capital, LP: 3.6 M
BlackRock, Inc.: 3.55 M
RTW INVESTMENTS, LP: 3.35 M
Paradigm Biocapital Advisors LP: 2.56 M
JANUS HENDERSON GROUP PLC: 2.24 M
MORGAN STANLEY: 1.94 M
105.51% of Tarsus Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 52.19 M shares in the last 24 months. This purchase volume represents approximately $3.89 B in transactions.